Incorporating genomics more widely into cancer screening and management will help to tackle the mortality gap between Black and white patients with cancer. Here, we emphasize the role of genomics as a tool to promote health equity in cancer.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Achieving the vision of genomics to improve health for all requires a focus on diversity, equity and inclusion
Journal of Community Genetics Open Access 21 July 2025
-
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations
Breast Cancer Research Open Access 25 May 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
American Cancer Society. Cancer Facts & Figures 2021 (American Cancer Society, 2021).
Murthy, V. H., Krumholz, H. M. & Gross, C. P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291, 2720–2726 (2004).
Winkfield, K. M. et al. American Society of Clinical Oncology strategic plan for increasing racial and ethnic diversity in the oncology workforce. J. Clin. Oncol. 35, 2576–2579 (2017).
[No authors listed.] 2020 snapshot: state of the oncology workforce in America. JCO Oncol. Pract. 17, 30 (2021).
Daly, B. & Olopade, O. I. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J. Clin. 65, 221–238 (2015).
Guindalini, R. S. C. et al. Intensive surveillance with biannual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clin. Cancer Res. 25, 1786–1794 (2019).
Kuhl, C. K. & Schrading, S. More is more: semiannual breast MRI screening in BRCA1 mutation carriers. Clin. Cancer Res. 25, 1693–1695 (2019).
Smith, J. J. et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 5, e185896 (2019).
Ibraheem, A., Olopade, O. I. & Huo, D. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base. Cancer 126, 4013–4022 (2020).
Dewdney, S. et al. Low rates of BRCA1 and BRCA2 testing for patients with ovarian cancer in ASCO’s CancerLinQ, a real-world database. J. Clin. Oncol. 38 (Suppl. 15), 6041 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
O.I.O. is a co-founder of CancerIQ, a scientific advisor for Tempus Inc., and serves on the board of directors of 54gene. O.D.B. declares no competing interests.
Rights and permissions
About this article
Cite this article
Balogun, O.D., Olopade, O.I. Addressing health disparities in cancer with genomics. Nat Rev Genet 22, 621–622 (2021). https://doi.org/10.1038/s41576-021-00390-4
Published:
Issue date:
DOI: https://doi.org/10.1038/s41576-021-00390-4
This article is cited by
-
Achieving the vision of genomics to improve health for all requires a focus on diversity, equity and inclusion
Journal of Community Genetics (2025)
-
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations
Breast Cancer Research (2023)
-
Harnessing big data to characterize immune-related adverse events
Nature Reviews Clinical Oncology (2022)
-
Biomarker benchmarking
Nature Reviews Genetics (2022)
